Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
I'm PortAI, I can summarize articles.
Regeneron Pharmaceuticals Inc. (REGN) shares rose 2.84% to $746.80 on Thursday, outperforming competitors like Amgen, Moderna, and Gilead Sciences. This marked the stock's second consecutive day of gains. The S&P 500 Index rose 0.21% and the Dow Jones Industrial Average rose 1.34%. Trading volume matched its 50-day average. REGN is 5.59% short of its 52-week high of $790.98 reached on November 26th.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments